[1]
C. Shibato, M. Otsuka, T. Kishikawa, T. Yoshikawa, A. Takata, and K. Koike, “Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma”, MCTM, vol. 1, no. 1, pp. 1–10, Mar. 2023.